Labcorp has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $255.01, representing a healthy ...

Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.

Since a new CEO moved Surgical Solutions to Kansas City 17 months ago, the company has been making significant strides, ...

Shares of Labcorp Holdings Inc. LH rose 1.31% to $251.04 Friday, on what proved to be an all-around positive trading session ...

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

Fintel reports that on March 4, 2025, Citigroup upgraded their outlook for Labcorp Holdings (NYSE:LH) from Neutral to Buy.

A vehicle crashed into the LabCorp business at 595 Loudon Rd in Newton Plaza II on March 4, causing significant damage to the ...

Citi upgraded Labcorp (LH) to Buy from Neutral with a price target of $300, up from $250. Utilization rates have been running high ...

This was the stock's second consecutive day of losses.

According to Benzinga Pro, Labcorp Hldgs's peer group average for short interest as a percentage of float is 9.75%, which ...

Few question the benefits of adopting a universal healthcare data exchange standard but achieving that goal will prove to be ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...